Neogen (NEOG) Cash from Operations (QoQ) (2010 - 2026)
Neogen (NEOG) Cash from Operations (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn |
| 10 | Neogen | 2.07 Bn | 1.91 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 16.76% |
| Nov 30, 2025 | 79.16% |
| Aug 31, 2025 | -34.00% |
| May 31, 2025 | -15.50% |
| Feb 28, 2025 | -51.65% |
| Nov 30, 2024 | 324.70% |
| Aug 31, 2024 | -166.98% |
| May 31, 2024 | 188.55% |
| Feb 29, 2024 | -292.22% |
| Nov 30, 2023 | -31.70% |
| Aug 31, 2023 | -74.71% |
| May 31, 2023 | 632.93% |
| Feb 28, 2023 | 8.85% |
| Nov 30, 2022 | -32.40% |
| Aug 31, 2022 | -169.36% |
| May 31, 2022 | 209.36% |
| Feb 28, 2022 | -63.07% |
| Nov 30, 2021 | -23.11% |
| Aug 31, 2021 | 5.65% |
| May 31, 2021 | 89.45% |